📰 BioSig Technologies Q2 2023 Results

💰 Key Financials:

- Net loss: US$11.1m (89% wider than 2Q 2022)

- Loss per share: US$0.16 (compared to US$0.15 in 2Q 2022)

🔮 Earnings Insights:

- Revenue forecast: 92% average annual growth over next 3 years

- Medical Equipment industry growth forecast: 7.9% in the US

📉 Stock Performance:

- Shares down 15% from a week ago

⚠️ Risk Analysis:

- 5 warning signs identified for BioSig Technologies

- 2 of these signs should not be ignored